PharmiWeb.com - Global Pharma News & Resources
28-Mar-2019

Transfusion Technology Market Is Expected To Reach Approximately Us$ 7,138 Million By 2026 | CAGR: 5.4%

Acumen Research and Consulting present a new research report titled "Transfusion Technology Market (By Product: Instruments [Apheresis System amp; Multicomponent Collection Systems, Cell Processing Systems amp; Cell Expansion Systems, Auto Transfusion Devices, Others], Disposables amp; Consumables; By End-user: Hospitals, Blood Banks, Biotechnology amp; Pharmaceutical Companies, Others ) - Global Industry Analysis, Market Size, Opportunities and Forecast, 2018 - 2026" that includes the analysis of the various segments of this market across the important regions in the world.

Theinternational transfusion technology marketrsquo;s worth is projected to touch USD 7,138 million by 2026 and the industry is anticipated to project a CAGR of 5.4% during the forthcoming years.

The worldwidetransfusion technology marketis described by an expansion in the occurrence of incessant sicknesses over the world. The market is growing at a fast pace, because of execution of government rules about security of transfusion. The worldwide transfusion technology market is anticipated to extend at a fast pace from 2018 to 2026.

Free Download Sample Report Pages for Better Understanding@ https://www.acumenresearchandconsulting.com/request-sample/1194

Expanding number of clinical medical procedures, and creating medicinal services foundation are required to fuel the worldwide transfusion technology market amid the figure time frame. North America is probably going to represent a noteworthy offer of the worldwide market amid the conjecture time frame, inferable from strong nearness of real players with set up dissemination arranges in the area. The transfusion technology market in Asia Pacific is anticipated to extend at a high CAGR from 2018 to 2026.

A transfusion technology device is an electromechanical gadget that guarantees the security of a patient amid blood transfusion and donation. Transfusion technology devices can be named apheresis framework, blood segment separators, cell development system, and auto transfusion gadgets. Apheresis is a technique performed either for donation of a blood segment or for treatment of an infection by evacuation of the ailing or ailment causing blood part. Entire blood is extricated from the contributor or patientrsquo;s body, handled through the apheresis machine, and the ideal blood segments are isolated dependent on their atomic weight, size, and fondness for specific substance, while the rest of the blood is transfused back to the donor or patient.

Increment in the geriatric populace, which is inclined to chronic diseases, expansive patient pool in developing nations requiring better health care facilities, and ventures by open and private players in Ramp;D on transfusion technology to guarantee end of transfusion-related diseases and diminish the danger of transfusion responses are key factors that are probably going to drive the worldwide transfusion technology market amid the figure time frame. In any case, lengthy process of obtaining regulatory approval, huge ventures required in the development of transfusion technology, and increment in negligibly obtrusive system that prompts low blood loss are probably going to limit the worldwide market amid the conjecture time frame. Transfusion technology devices are picking up notoriety among health care professionals, as these have ended up being viable in decreasing transfusion response. Rising investment for advancement in transfusion technology and organizations for co-improvement and commercialization of these gadgets are relied upon to fuel the worldwide transfusion technology market sooner rather than later.

View Detail Information with Complete TOC@ https://www.acumenresearchandconsulting.com/transfusion-technology-market

The global transfusion technology market has been classified into product, end-user and region. Based on product, the global transfusion technology market is segregated into instruments (apheresis system amp; multicomponent collection systems, cell processing systems amp; cell expansion systems, auto transfusion devices, others) and disposables amp; consumables. On the basis of end-user, the global transfusion technology market is segregated into hospitals, blood banks, biotechnology amp; pharmaceutical companies and others. On the basis of region, the global transfusion technology market is bifurcated into North America, Latin America, Europe, Middle East amp; Africa, and Asia Pacific.

North America and Europe represented a huge offer of the worldwide transfusion technology market in 2017. This can be credited to high health care expenditure, high rate of apheresis for treatment of chronic diseases, for example, chronic kidney disease, driven by increment in the commonness of way of life related infections, rise in mindfulness about importance of careful blood, high market penetration of recently created transfusion technology gadgets, favourable reimbursement policies guaranteeing business development for new market contestants, and nearness of real players in the two areas. Notwithstanding, changes in repayment and protection approaches in 2017 and stringent administrative system for generation of medical gadgets in the U.S. are probably going to hamper the transfusion technology market in North America in the following couple of years. Asia Pacific is probably going to offer noteworthy chances to the transfusion technology market amid the figure time frame, attributable to an expansion in the geriatric populace, ascend in the appropriation of transfusion technology gadgets driven by mindfulness about their focal points, and flood in the occurrence of transfusion- acquired infections in the area.

Market Players

The key organization in the global transfusion technology market are LivaNova PLC., Haemonetics Corporation, Inc., Medtronic plc, TERUMO BCT, Asahi Kasei Medical Co., Ltd., Miltenyi Biotec, B. Braun Melsungen AG, GE Healthcare, Cerus Corporation, and Fresenius Kabi AG (Fresenius SE amp; Co. KGaA).

Browse More Press Releases, Click Here: https://www.acumenresearchandconsulting.com/press-releases

TABLE OF CONTENT

CHAPTER 1. INDUSTRY OVERVIEW

1.1. Definition and Scope
1.1.1. Definition of Transfusion Technology
1.1.2. Market Segmentation
1.1.3. List of Abbreviations
1.2. Summary
1.2.1. Market Snapshot
1.2.2. Transfusion Technology Market By Product
1.2.2.1. Global Transfusion Technology Market Revenue and Growth Rate Comparison By Product (2015-2026)
1.2.2.2. Global Transfusion Technology Market Revenue Share By Product in 2017
1.2.2.3. Instruments
1.2.2.4. Disposables amp; Consumables
1.2.3. Transfusion Technology Market By End-user
1.2.3.1. Global Transfusion Technology Market Revenue and Growth Rate Comparison By End-user (2015-2026)
1.2.3.2. Global Transfusion Technology Market Revenue Share By End-user in 2017
1.2.3.3. Hospitals
1.2.3.4. Blood Banks
1.2.3.5. Biotechnology amp; Pharmaceutical Companies
1.2.3.6. Others
1.2.4. Transfusion Technology Market by Geography
1.2.4.1. Global Transfusion Technology Market Revenue and Growth Rate Comparison by Geography (2015-2026)
1.2.4.2. North America Transfusion Technology Market Revenue and Growth Rate (2015-2026)
1.2.4.3. Europe Transfusion Technology Market Revenue and Growth Rate (2015-2026)
1.2.4.4. Asia-Pacific Transfusion Technology Market Revenue and Growth Rate (2015-2026)
1.2.4.5. Latin America Transfusion Technology Market Revenue and Growth Rate (2015-2026)
1.2.4.6. Middle East and Africa (MEA) Transfusion Technology Market Revenue and Growth Rate (2015-2026)

CHAPTER 2. MARKET DYNAMICS AND COMPETITION ANALYSIS

2.1. Market Drivers
2.2. Restraints and Challenges
2.3. Growth Opportunities
2.4. Porterrsquo;s Five Forces Analysis
2.4.1. Bargaining Power of Suppliers
2.4.2. Bargaining Power of Buyers
2.4.3. Threat of Substitute
2.4.4. Threat of New Entrants
2.4.5. Degree of Competition
2.5. Value Chain Analysis
2.6. Cost Structure Analysis
2.6.1. Raw Material and Suppliers
2.6.2. Manufacturing Process Analysis
2.7. Regulatory Compliance
2.8. Competitive Landscape, 2017
2.8.1. Player Positioning Analysis
2.8.2. Key Strategies Adopted By Leading Players

CHAPTER 3. MANUFACTURING PLANTS ANALYSIS

3.1. Capacity and Commercial Production Date of Global Transfusion Technology Major Manufacturers in 2017
3.2. Manufacturing Plants Distribution of Global Transfusion Technology Major Manufacturers in 2017
3.3. Ramp;D Status and Technology Source of Global Transfusion Technology Major Manufacturers in 2017
3.4. Raw Materials Sources Analysis of Global Transfusion Technology Major Manufacturers in 2017

CHAPTER 4. PURE CASHMERE MARKET BY PRODUCT

4.1. Global Transfusion Technology Revenue By Product
4.2. Instruments
4.2.1. Market Revenue and Growth Rate, 2015 ndash; 2026 ($Million)
4.2.2. Market Revenue and Forecast, By Region, 2015 ndash; 2026 ($Million)
4.3. Disposables amp; Consumables
4.3.1. Market Revenue and Growth Rate, 2015 ndash; 2026 ($Million)
4.3.2. Market Revenue and Forecast, By Region, 2015 ndash; 2026 ($Million)

CHAPTER 5. PURE CASHMERE MARKET BY END-USER

5.1. Global Transfusion Technology Revenue By End-user
5.2. Hospitals
5.2.1. Market Revenue and Growth Rate, 2015 ndash; 2026 ($Million)
5.2.2. Market Revenue and Forecast, By Region, 2015 ndash; 2026 ($Million)
5.3. Blood Banks
5.3.1. Market Revenue and Growth Rate, 2015 ndash; 2026 ($Million)
5.3.2. Market Revenue and Forecast, By Region, 2015 ndash; 2026 ($Million)
5.4. Biotechnology amp; Pharmaceutical Companies
5.4.1. Market Revenue and Growth Rate, 2015 ndash; 2026 ($Million)
5.4.2. Market Revenue and Forecast, By Region, 2015 ndash; 2026 ($Million)
5.5. Others
5.5.1. Market Revenue and Growth Rate, 2015 ndash; 2026 ($Million)
5.5.2. Market Revenue and Forecast, By Region, 2015 ndash; 2026 ($Million)

CHAPTER 6. NORTH AMERICA PURE CASHMERE MARKET BY COUNTRY

6.1. North America Transfusion Technology Market Revenue and Growth Rate, 2015 ndash; 2026 ($Million)
6.2. North America Transfusion Technology Market Revenue Share Comparison, 2015 amp; 2026 (%)
6.3. U.S.
6.3.1. U.S. Transfusion Technology Market Revenue and Forecast By Product, 2015 ndash; 2026 ($Million)
6.3.2. Market Revenue and Forecast By End-user, 2015 ndash; 2026 ($Million)
6.4. Canada
6.4.1. Market Revenue and Forecast By Product, 2015 ndash; 2026 ($Million)
6.4.2. Market Revenue and Forecast By End-user, 2015 ndash; 2026 ($Million)
6.5. Mexico
6.5.1. Market Revenue and Forecast By Product, 2015 ndash; 2026 ($Million)
6.5.2. Market Revenue and Forecast By End-user, 2015 ndash; 2026 ($Million)

CHAPTER 7. EUROPE PURE CASHMERE MARKET BY COUNTRY

7.1. Europe Transfusion Technology Market Revenue and Growth Rate, 2015 ndash; 2026 ($Million)
7.2. Europe Transfusion Technology Market Revenue Share Comparison, 2015 amp; 2026 (%)
7.3. UK
7.3.1. Market Revenue and Forecast By Product, 2015 ndash; 2026 ($Million)
7.3.2. Market Revenue and Forecast By End-user, 2015 ndash; 2026 ($Million)
7.4. Germany
7.4.1. Market Revenue and Forecast By Product, 2015 ndash; 2026 ($Million)
7.4.2. Market Revenue and Forecast By End-user, 2015 ndash; 2026 ($Million)
7.5. France
7.5.1. Market Revenue and Forecast By Product, 2015 ndash; 2026 ($Million)
7.5.2. Market Revenue and Forecast By End-user, 2015 ndash; 2026 ($Million)
7.6. Spain
7.6.1. Market Revenue and Forecast By Product, 2015 ndash; 2026 ($Million)
7.6.2. Market Revenue and Forecast By End-user, 2015 ndash; 2026 ($Million)
7.7. Rest of Europe
7.7.1. Market Revenue and Forecast By Product, 2015 ndash; 2026 ($Million)
7.7.2. Market Revenue and Forecast By End-user, 2015 ndash; 2026 ($Million)

CHAPTER 8. ASIA-PACIFIC PURE CASHMERE MARKET BY COUNTRY

8.1. Asia-Pacific Transfusion Technology Market Revenue and Growth Rate, 2015 ndash; 2026 ($Million)
8.2. Asia-Pacific Transfusion Technology Market Revenue Share Comparison, 2015 amp; 2026 (%)
8.3. China
8.3.1. Market Revenue and Forecast By Product, 2015 ndash; 2026 ($Million)
8.3.2. Market Revenue and Forecast By End-user, 2015 ndash; 2026 ($Million)
8.4. Japan
8.4.1. Market Revenue and Forecast By Product, 2015 ndash; 2026 ($Million)
8.4.2. Market Revenue and Forecast By End-user, 2015 ndash; 2026 ($Million)
8.5. India
8.5.1. Market Revenue and Forecast By Product, 2015 ndash; 2026 ($Million)
8.5.2. Market Revenue and Forecast By End-user, 2015 ndash; 2026 ($Million)
8.6. Australia
8.6.1. Market Revenue and Forecast By Product, 2015 ndash; 2026 ($Million)
8.6.2. Market Revenue and Forecast By End-user, 2015 ndash; 2026 ($Million)
8.7. South Korea
8.7.1. Market Revenue and Forecast By Product, 2015 ndash; 2026 ($Million)
8.7.2. Market Revenue and Forecast By End-user, 2015 ndash; 2026 ($Million)
8.8. Rest of Asia-Pacific
8.8.1. Market Revenue and Forecast By Product, 2015 ndash; 2026 ($Million)
8.8.2. Market Revenue and Forecast By End-user, 2015 ndash; 2026 ($Million)

CHAPTER 9. LATIN AMERICA PURE CASHMERE MARKET BY COUNTRY

9.1. Latin America Transfusion Technology Market Revenue and Growth Rate, 2015 ndash; 2026 ($Million)
9.2. Latin America Transfusion Technology Market Revenue Share Comparison, 2015 amp; 2026 (%)
9.3. Brazil
9.3.1. Market Revenue and Forecast By Product, 2015 ndash; 2026 ($Million)
9.3.2. Market Revenue and Forecast By End-user, 2015 ndash; 2026 ($Million)
9.4. Argentina
9.4.1. Market Revenue and Forecast By Product, 2015 ndash; 2026 ($Million)
9.4.2. Market Revenue and Forecast By End-user, 2015 ndash; 2026 ($Million)
9.5. Rest of Latin America
9.5.1. Market Revenue and Forecast By Product, 2015 ndash; 2026 ($Million)
9.5.2. Market Revenue and Forecast By End-user, 2015 ndash; 2026 ($Million)

CHAPTER 10. MIDDLE EAST PURE CASHMERE MARKET BY COUNTRY

10.1. Middle East Transfusion Technology Market Revenue and Growth Rate, 2015 ndash; 2026 ($Million)
10.2. Middle East Transfusion Technology Market Revenue Share Comparison, 2015 amp; 2026 (%)
10.3. Saudi Arabia
10.3.1. Market Revenue and Forecast By Product, 2015 ndash; 2026 ($Million)
10.3.2. Market Revenue and Forecast By End-user, 2015 ndash; 2026 ($Million)
10.4. UAE
10.4.1. Market Revenue and Forecast By Product, 2015 ndash; 2026 ($Million)
10.4.2. Market Revenue and Forecast By End-user, 2015 ndash; 2026 ($Million)
10.5. Rest of Middle East
10.5.1. Market Revenue and Forecast By Product, 2015 ndash; 2026 ($Million)
10.5.2. Market Revenue and Forecast By End-user, 2015 ndash; 2026 ($Million)

CHAPTER 11. AFRICA PURE CASHMERE MARKET BY COUNTRY

11.1. Africa Transfusion Technology Market Revenue and Growth Rate, 2015 ndash; 2026 ($Million)
11.2. Africa Transfusion Technology Market Revenue Share Comparison, 2015 amp; 2026 (%)
11.3. South Africa
11.3.1. Market Revenue and Forecast By Product, 2015 ndash; 2026 ($Million)
11.3.2. Market Revenue and Forecast By End-user, 2015 ndash; 2026 ($Million)
11.4. Egypt
11.4.1. Market Revenue and Forecast By Product, 2015 ndash; 2026 ($Million)
11.4.2. Market Revenue and Forecast By End-user, 2015 ndash; 2026 ($Million)
11.5. Rest of Africa
11.5.1. Market Revenue and Forecast By Product, 2015 ndash; 2026 ($Million)
11.5.2. Market Revenue and Forecast By End-user, 2015 ndash; 2026 ($Million)

CHAPTER 12. COMPANY PROFILE

12.1. LivaNova PLC.
12.1.1. Company Snapshot
12.1.2. Overview
12.1.3. Financial Overview
12.1.4. Product Portfolio
12.1.5. Key Developments
12.1.6. Strategies
12.2. Haemonetics Corporation, Inc.
12.2.1. Company Snapshot
12.2.2. Overview
12.2.3. Financial Overview
12.2.4. Product Portfolio
12.2.5. Key Developments
12.2.6. Strategies
12.3. Medtronic plc
12.3.1. Company Snapshot
12.3.2. Overview
12.3.3. Financial Overview
12.3.4. Product Portfolio
12.3.5. Key Developments
12.3.6. Strategies
12.4. TERUMO BCT
12.4.1. Company Snapshot
12.4.2. Overview
12.4.3. Financial Overview
12.4.4. Product Portfolio
12.4.5. Key Developments
12.4.6. Strategies
12.5. Asahi Kasei Medical Co., Ltd.
12.5.1. Company Snapshot
12.5.2. Overview
12.5.3. Financial Overview
12.5.4. Product Portfolio
12.5.5. Key Developments
12.5.6. Strategies
12.6. MiltenyiBiotec
12.6.1. Company Snapshot
12.6.2. Overview
12.6.3. Financial Overview
12.6.4. Product Portfolio
12.6.5. Key Developments
12.6.6. Strategies
12.7. B. Braun Melsungen AG
12.7.1. Company Snapshot
12.7.2. Overview
12.7.3. Financial Overview
12.7.4. Product Portfolio
12.7.5. Key Developments
12.7.6. Strategies
12.8. GE Healthcare, Cerus Corporation
12.8.1. Company Snapshot
12.8.2. Overview
12.8.3. Financial Overview
12.8.4. Product Portfolio
12.8.5. Key Developments
12.8.6. Strategies
12.9. Fresenius Kabi AG (Fresenius SE amp; Co. KGaA)
12.9.1. Company Snapshot
12.9.2. Overview
12.9.3. Financial Overview
12.9.4. Product Portfolio
12.9.5. Key Developments
12.9.6. Strategies

CHAPTER 13. RESEARCH APPROACH

13.1. Research Methodology
13.1.1. Initial Data Search
13.1.2. Secondary Research
13.1.3. Primary Research
13.2. Assumptions and Scope

INQUIRY BEFORE BUYING@ https://www.acumenresearchandconsulting.com/inquiry-before-buying/1194

The report is readily available and can be dispatched immediately after payment confirmation.

To Purchase this Premium Report@ https://www.acumenresearchandconsulting.com/buy-now/0/1194

Would like to place an order or any question, please feel free to contact atsales@acumenresearchandconsulting.com| +1 407 915 4157

Editor Details

Last Updated: 28-Mar-2019